Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

被引:7
|
作者
Siripuram, Vijay K. [1 ]
Wright, Daniel F. B. [1 ]
Barclay, Murray L. [2 ,3 ]
Duffull, Stephen B. [1 ]
机构
[1] Univ Otago, Sch Pharm, Otago Pharmacometr Grp, Dunedin, New Zealand
[2] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand
[3] Christchurch Hosp, Dept Clin Pharmacol, Christchurch, New Zealand
关键词
Identifiability; Parameter precision; Population analysis; PKPD models; Optimal study design; NONMEM; MIXED-EFFECTS MODELS; 4 BASIC MODELS; STRUCTURAL IDENTIFIABILITY; GLOBAL IDENTIFIABILITY; COMPARTMENTAL-MODELS; PARAMETER-ESTIMATION; DESIGN; RESPONSES; SYSTEMS; INDISTINGUISHABILITY;
D O I
10.1007/s10928-017-9530-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Identifiability is an important component of pharmacokinetic-pharmacodynamic (PKPD) model development. Structural identifiability is concerned with the uniqueness of the model parameters for a set of perfect input-output data and deterministic identifiability with the precision of parameter estimation given imperfect input-output data. We introduce two subcategories of deterministic identifiability, external and internal, and consider factors that distinguish between these forms. We define external deterministic identifiability as a function of externally controllable variables, i.e., the design, and internal deterministic identifiability as a function of the model and its parameter values. The concepts are explored using three common PK and PKPD models, and verified for their precision for the selected set of parameter values under optimal design.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 50 条
  • [31] Pharmacokinetic-pharmacodynamic modeling:: Why?
    Pérez-Urizar, J
    Granados-Soto, V
    Flores-Murrieta, FJ
    Castañeda-Hernández, G
    ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (06) : 539 - 545
  • [33] Pharmacokinetic-pharmacodynamic relationships for analgesics
    Suri, A
    Estes, KS
    Geisslinger, G
    Derendorf, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (08) : 307 - 323
  • [34] Pharmacokinetic-pharmacodynamic modeling of opioids
    Lötsch, JR
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : S90 - S103
  • [35] Pharmacokinetic-pharmacodynamic relationships for benzodiazepines
    Laurijssens, BE
    Greenblatt, DJ
    CLINICAL PHARMACOKINETICS, 1996, 30 (01) : 52 - 76
  • [36] Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis
    Kloprogge, Frank
    Mwandumba, Henry C.
    Banda, Gertrude
    Kamdolozi, Mercy
    Shani, Doris
    Corbett, Elizabeth L.
    Kontogianni, Nadia
    Ward, Steve
    Khoo, Saye H.
    Davies, Geraint R.
    Sloan, Derek J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (07):
  • [37] Pharmacokinetic-pharmacodynamic correlations in psychopharmacology
    Danhof, M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S112 - S113
  • [38] Microdialysis for pharmacokinetic-pharmacodynamic studies
    Yu, W.
    Cheng, Q.
    Feng, J.
    Li, F.
    PHARMAZIE, 2007, 62 (12): : 883 - 891
  • [39] PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PAIN
    Loetsch, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 14 - 14
  • [40] Pharmacokinetic-pharmacodynamic modelling in anaesthesia
    Gambus, Pedro L.
    Troconiz, Inaki F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 72 - 84